Company intelligence / Profile preview

Fourth Frontier Technologies LLC

Austin, Texas, United Statesfourthfrontier.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company's main product line includes the FDA-cleared "Frontier X Plus," a chest-worn wearable that provides continuous real-time ECG monitoring and AI-powered arrhythmia detection. It enables early detection of arrhythmias such as atrial fibrillation and supports remote patient monitoring. The technology has been adopted by cardiologists, rehab centers, researchers globally and has over 18,000 users worldwide. No traditional drug pipeline or clinical trial results.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health platformAI-powered ECG analysis
Industry: Physiological Monitoring

Partnerships

Not explicitly listed in sources. Company states it works with leading cardiologists and cardiac rehab centers globally.

Beyond the preview

Go deeper on Fourth Frontier Technologies LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fourth Frontier Technologies LLC.

Explore the full profile